Metilfenidat hydrochloride en es it fr

Metilfenidat hydrochloride Brand names, Metilfenidat hydrochloride Analogs

Metilfenidat hydrochloride Brand Names Mixture

  • No information avaliable

Metilfenidat hydrochloride Chemical_Formula

C14H19NO2

Metilfenidat hydrochloride RX_link

http://www.rxlist.com/cgi/generic/methphen.htm

Metilfenidat hydrochloride fda sheet

Metilfenidat_hydrochloride FDA

Metilfenidat hydrochloride msds (material safety sheet)

Metilfenidat_hydrochloride MSDS

Metilfenidat hydrochloride Synthesis Reference

M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)

Metilfenidat hydrochloride Molecular Weight

233.306 g/mol

Metilfenidat hydrochloride Melting Point

224-226oC

Metilfenidat hydrochloride H2O Solubility

1255mg/L

Metilfenidat hydrochloride State

Solid

Metilfenidat hydrochloride LogP

3.192

Metilfenidat hydrochloride Dosage Forms

Tablets; Tablets (sustained release)

Metilfenidat hydrochloride Indication

For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Metilfenidat hydrochloride Pharmacology

Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.

Metilfenidat hydrochloride Absorption

Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)

Metilfenidat hydrochloride side effects and Toxicity

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)

Metilfenidat hydrochloride Patient Information

Metilfenidat hydrochloride Organisms Affected

Humans and other mammals